SCIENTURE HOLDINGS INC (SCNX) Stock Price, Quote, News and Overview
NASDAQ:SCNX - Nasdaq - US80880X1046 - Common Stock - Currency: USD
SCNX Quote, Performance and Key Statistics
1.58
-0.83 (-34.44%)
The current stock price of SCNX is 1.58 USD. In the past month the price decreased by -56.05%.
SCNX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.34 | 40.07B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.98 | 12.01B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.44B | ||
| CERT | CERTARA INC | 26.07 | 1.89B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 13.97 | 1.77B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.59B | ||
| SDGR | SCHRODINGER INC | N/A | 1.54B | ||
| PHR | PHREESIA INC | N/A | 1.38B | ||
| EVH | EVOLENT HEALTH INC - A | 13.62 | 1.05B | ||
| HSTM | HEALTHSTREAM INC | 49.74 | 999.02M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 989.63M | ||
| SLP | SIMULATIONS PLUS INC | 70.58 | 567.14M |
Related stock screener links
About SCNX
Company Profile
Scienture Holdings Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. The company operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Company Info
SCIENTURE HOLDINGS INC
2420 Brunello Trace
Lutz FLORIDA US
Employees: 8
Company Website: https://www.trxadehealth.com/
Investor Relations: http://investors.trxadegroup.com/
Phone: 18002610281
SCIENTURE HOLDINGS INC / SCNX FAQ
What is the stock price of SCIENTURE HOLDINGS INC today?
The current stock price of SCNX is 1.58 USD. The price decreased by -34.44% in the last trading session.
What is the ticker symbol for SCIENTURE HOLDINGS INC stock?
The exchange symbol of SCIENTURE HOLDINGS INC is SCNX and it is listed on the Nasdaq exchange.
On which exchange is SCNX stock listed?
SCNX stock is listed on the Nasdaq exchange.
What is SCIENTURE HOLDINGS INC worth?
SCIENTURE HOLDINGS INC (SCNX) has a market capitalization of 20.81M USD. This makes SCNX a Nano Cap stock.
How many employees does SCIENTURE HOLDINGS INC have?
SCIENTURE HOLDINGS INC (SCNX) currently has 8 employees.
Is SCIENTURE HOLDINGS INC (SCNX) expected to grow?
The Revenue of SCIENTURE HOLDINGS INC (SCNX) is expected to grow by 4.1% in the next year. Check the estimates tab for more information on the SCNX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SCIENTURE HOLDINGS INC (SCNX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SCNX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SCNX, evaluating the profitability, health, valuation and growth aspects
- SCIENTURE HOLDINGS INC (SCNX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SCIENTURE HOLDINGS INC (SCNX) Sales and EPS estimates to see what analysts future expectations are.
- SCIENTURE HOLDINGS INC (SCNX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SCIENTURE HOLDINGS INC (SCNX) Insider and Institutional Ownership to learn about the owners and their transactions.
- SCIENTURE HOLDINGS INC (SCNX) Stock Chart to make your own analysis
- SCIENTURE HOLDINGS INC (SCNX) Latest news and press-releases to stay up to date.
Does SCIENTURE HOLDINGS INC (SCNX) stock pay dividends?
SCIENTURE HOLDINGS INC (SCNX) has a dividend yield of 601.27%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of SCNX dividend history, reliability and sustainability.
When does SCIENTURE HOLDINGS INC (SCNX) report earnings?
SCIENTURE HOLDINGS INC (SCNX) will report earnings on 2025-04-21, after the market close.
What is the Price/Earnings (PE) ratio of SCIENTURE HOLDINGS INC (SCNX)?
SCIENTURE HOLDINGS INC (SCNX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.29).
What is the Short Interest ratio of SCIENTURE HOLDINGS INC (SCNX) stock?
The outstanding short interest for SCIENTURE HOLDINGS INC (SCNX) is 0.45% of its float. Check the ownership tab for more information on the SCNX short interest.
SCNX Technical Analysis
SCNX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SCNX. No worries on liquidiy or solvency for SCNX as it has an excellent financial health rating, but there are worries on the profitability.
SCNX Financial Highlights
Over the last trailing twelve months SCNX reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS increased by 63.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 94.17% | ||
| ROA | 28.09% | ||
| ROE | 35.39% | ||
| Debt/Equity | 0 |
SCNX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to SCNX. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 4.1% for SCNX